4th International Conference on
Infectious Diseases
September 09-10, 2026 | Barcelona, Spain
Tuberculosis and Respiratory Diseases
Tuberculosis (TB) and respiratory diseases continue to affect millions worldwide, particularly in low-resource settings. Caused mainly by Mycobacterium tuberculosis, TB spreads through airborne droplets and requires effective screening, early diagnosis, and long-term treatment. Other respiratory diseases—such as pneumonia, influenza, and chronic lung conditions - remain significant contributors to global morbidity and mortality.
Advancements in vaccines, molecular diagnostics, and therapeutic strategies are improving patient outcomes. Strengthening healthcare infrastructure, expanding public awareness, and ensuring rapid access to care are key priorities. Continued research and international collaboration help address emerging drug-resistant TB strains and evolving respiratory pathogens.
- Spread mainly via airborne transmission.
- Requires early diagnosis and treatment.
- Faces drug-resistant challenges.